New inhaled asthma drug shows promise in early trial
NCT ID NCT05276570
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 26 times
Summary
This early-stage study tested an inhaled drug called ARO-RAGE in 127 healthy volunteers and people with asthma. The goal was to check safety and how the drug affects lung function. Participants received either the drug or a placebo, and researchers monitored side effects and breathing tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site 1
Nedlands, Washington, 6009, Australia
-
Research Site 1
Auckland, 1010, New Zealand
-
Research Site 1
Barcelona, 08017, Spain
-
Research Site 1
Bangkok Noi, Bangkok, 10700, Thailand
-
Research Site 2
Auckland, 1051, New Zealand
-
Research Site 2
Krakow, 31-455, Poland
-
Research Site 3
Auckland, 622, New Zealand
-
Research Site 3
Oświęcim, 32-600, Poland
Conditions
Explore the condition pages connected to this study.